Biomira and Merck KGAA to co-promote cancer vaccines
In an effort to build up an oncology drug business, Merck KGAA will develop and co-promote cancer management company Biomira's flagship vaccines, Theratope and BLP25, for all oncological indications.
- Large Molecule
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com